Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
Why Insulet (PODD) is a Top Momentum Stock for the Long-Term
10:51am, Monday, 25'th Aug 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Insulet Gains 77.2% in a Year: What's Driving the Rally?
10:55am, Friday, 22'nd Aug 2025
PODD's 77.2% stock surge is fueled by Omnipod 5 expansion, global launches, strong Q2 profits and robust financial stability.
Omnipod Maker Hit A Buy Point. Here's Where To Pick Up Shares.
12:51pm, Wednesday, 20'th Aug 2025
The Omnipod maker reported 113% earnings growth, sending shares higher.
Final Trades: Rocket Companies, Cisco Systems, Insulet Corp and the IGV
01:20pm, Tuesday, 19'th Aug 2025
The Investment Committee give you their top stocks to watch for the second half.
Insulet to Participate in Upcoming Investor Conferences
06:00am, Tuesday, 19'th Aug 2025
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will pres
Insulet's Q2 Beat Is Impressive, But The Elevated Valuation Makes The Stock A Hold
11:49pm, Wednesday, 13'th Aug 2025
PODD delivered strong Q2 results, exceeding revenue guidance, improving gross margin, and launching the Omnipod 5 iPhone app, strengthening its ecosystem position. Omnipod 5's pharmacy channel penetra
Insulet Q2 Earnings & Revenues Beat Estimates, Stock Up, Margins Rise
09:26am, Tuesday, 12'th Aug 2025
PODD posts strong Q2 earnings and revenues and lifts its 2025 outlook, marking a decade of 20%+ constant-currency growth.
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
10:46am, Monday, 11'th Aug 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5
01:08pm, Thursday, 07'th Aug 2025
Insulet Corporation PODD reported second-quarter adjusted earnings of $1.17 per share, beating the consensus of 92 cents.
Insulet Corporation (PODD) Q2 2025 Earnings Call Transcript
11:14am, Thursday, 07'th Aug 2025
Insulet Corporation (NASDAQ:PODD ) Q2 2025 Earnings Call August 7, 2025 8:00 AM ET Company Participants Ana Maria Chadwick - Executive VP & CFO Ashley A. McEvoy - CEO, President & Director Eric Benjam
Insulet (PODD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
10:31am, Thursday, 07'th Aug 2025
While the top- and bottom-line numbers for Insulet (PODD) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to
Insulet (PODD) Q2 Revenue Jumps 33%
09:36am, Thursday, 07'th Aug 2025
Insulet (PODD 9.87%), a medical device company specializing in wearable insulin delivery systems, released its second quarter 2025 earnings on August 7, 2025. The headline news was strong outperforman
Insulet (PODD) Surpasses Q2 Earnings and Revenue Estimates
09:16am, Thursday, 07'th Aug 2025
Insulet (PODD) came out with quarterly earnings of $1.17 per share, beating the Zacks Consensus Estimate of $0.93 per share. This compares to earnings of $0.55 per share a year ago.
Insulet Pops As Diabetes Medtech Continues Its Streak Of 'Impressive Beat-And-Raises'
09:13am, Thursday, 07'th Aug 2025
Insulet stock surged Thursday after the insulin pump-maker walloped second-quarter forecasts and raised its sales guidance for the year.
Insulet beats second-quarter profit estimates on strong demand for insulin pumps
08:39am, Thursday, 07'th Aug 2025
Medical device maker Insulet beat Wall Street estimates for second-quarter profit and revenue on strong demand for its wearable insulin pumps, sending its shares up nearly 10% in premarket trading on
